Plain-English translation of NCT07401225 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing transcranial magnetic stimulation (TMS) — a non-invasive brain treatment — for young people ages 12–20 who still have PTSD symptoms after completing talk therapy. TMS uses magnetic pulses to gently stimulate areas of the brain thought to be involved in PTSD. Researchers want to learn whether this treatment can help reduce lingering symptoms like upsetting memories, avoidance, and emotional numbing.
Most young people benefit from talk therapy for PTSD, but some continue to struggle with symptoms long afterward. Doctors don't yet know the best way to help these young people, so this trial is testing whether this medication can fill that gap.
You likely qualify if…
You likely don't qualify if…
Over about 4 months, you would attend 16 visits total — 6 for research assessments and 10 for treatment. Research visits include screening, interviews, two brain scans (MRI), and follow-up check-ins; most can be done online. During each 1.5-hour treatment visit, you would receive up to four 10-minute brain stimulation sessions, followed by a brief talk with a therapist. You would also complete questionnaires about your symptoms at the end of treatment and again 1 and 3 months later.
AI-generated summary from trial data · Jul 15, 2026 · Not medical advice
United States